Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial by Ramakrishnan, S, Nicolau, D, Langford, B, Mahdi, M, Jeffers, H, Mwasuku, C, Krassowska, K, Fox, R, Binnian, I, Glover, V, Bright, S, Butler, C, Cane, J, Halner, A, Matthews, P, Donnelly, L, Simpson, J, Baker, J, Fadai, N, Peterson, S, Bengtsson, T, Barnes, P, Russell, R, Bafadhel, M